Jason P. Holland completed his doctorate in Inorganic, Computational and Radiochemistry at the University of Oxford, UK in 2008. He trained as a Post-doctoral Scholar at Memorial Sloan-Kettering Cancer Center, New York, in the laboratory of Prof. Jason S. Lewis and as a Senior Fellow the ETH Zurich in Switzerland. He was appointed Assistant Chemist in 2012 at Massachusetts General Hospital, Harvard Medical School. He has published more than 50 research papers and serves on the editorial board of several journals including the Journal of Nuclear Medicine. His research concentrates on the development and translation of new metal-based radiopharmaceuticals for PET imaging in oncology Jason P. Holland completed his doctorate in Inorganic, Computational and Radiochemistry at the University of Oxford, UK in 2008. He trained as a Post-doctoral Scholar at Memorial Sloan-Kettering Cancer Center, New York, in the laboratory of Prof. Jason S. Lewis and as a Senior Fellow the ETH Zurich in Switzerland. He was appointed Assistant Chemist in 2012 at Massachusetts General Hospital, Harvard Medical School. He has published more than 50 research papers and serves on the editorial board of several journals including the Journal of Nuclear Medicine. His research concentrates on the development and translation of new metal-based radiopharmaceuticals for PET imaging in oncology

Gastroenterology